Stephen George Dilly, President and CEO at Aimmune Therapeutics, Inc. (AIMT), sold 50,000 shares at $21.46 ($1.1M) on 2017-07-26, disclosed to the SEC on 2017-07-28.
Open-market sale of $1.1M AIMT by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SRRA | BUY | 2021-05-20 | $178K | — | Filing → |
| SGMO | SELL | 2020-03-20 | $210K | — | Filing → |
| SGMO | SELL | 2020-03-18 | $90K | — | Filing → |